$0.30 EPS Expected for MedEquities Realty Trust, Inc. (MRT)

October 13, 2018 - By Hazel Jackson

Analysts expect MedEquities Realty Trust, Inc. (NYSE:MRT) to report $0.30 EPS on November, 6.They anticipate $0.01 EPS change or 3.45 % from last quarter’s $0.29 EPS. MRT’s profit would be $9.56 million giving it 7.33 P/E if the $0.30 EPS is correct. After having $0.30 EPS previously, MedEquities Realty Trust, Inc.’s analysts see 0.00 % EPS growth. The stock decreased 0.45% or $0.04 during the last trading session, reaching $8.79. About 151,484 shares traded. MedEquities Realty Trust, Inc. (NYSE:MRT) has declined 11.96% since October 14, 2017 and is downtrending. It has underperformed by 27.58% the S&P500.

MedEquities Realty Trust is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The company has market cap of $280.07 million. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios. It has a 14.41 P/E ratio. MedEquities' strategy is to become an integral capital partner with high-quality and growth-oriented facility providers of healthcare services on a nationwide basis, primarily through net-leased real estate investment.

Another recent and important MedEquities Realty Trust, Inc. (NYSE:MRT) news was published by Globenewswire.com which published an article titled: “Detailed Research: Economic Perspectives on Empire State Realty Trust, Healthcare Services Group, American Renal …” on October 04, 2018.

MedEquities Realty Trust, Inc. (NYSE:MRT) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: